Polycystic ovary syndrome does affect libido, though not always in the direction people expect. Despite the condition’s hallmark of elevated androgens, which are often loosely called “sex drive hormones,” research consistently finds that women with PCOS report lower sexual desire, arousal, and overall sexual satisfaction compared to women without the condition. A systematic meta-analysis estimated that women with PCOS have about a third higher odds of sexual dysfunction than those without it, and the desire domain is one of the most frequently impaired. The reasons turn out to have less to do with hormone levels on a lab report and more to do with a tangle of metabolic, psychological, and physical factors that the condition drags along with it.
How Common Are Sexual Difficulties in PCOS
Studies consistently report higher rates of sexual problems in women with PCOS, though the exact numbers vary depending on how dysfunction is measured and which population is studied. In one study of 130 women with PCOS, nearly 58% met the clinical threshold for sexual dysfunction, with desire and arousal being the most commonly affected areas.1PubMed Central. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains A case-control study published in Human Reproduction found that women with PCOS scored significantly lower across almost every dimension of sexual function compared to matched controls, including desire, arousal, lubrication, orgasm, and satisfaction. The one exception was pain during intercourse, which did not differ between groups.2Human Reproduction. Sexual dysfunction in women with PCOS: a case control study
A meta-analysis pooling data from multiple studies put the overall prevalence of female sexual dysfunction at about 35% in women with PCOS versus roughly 30% in women without it. That gap might seem modest, but it translated into statistically meaningful higher odds of dysfunction in the PCOS group, with satisfaction and pain domains showing the clearest differences.3PubMed. Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis Importantly, the findings held even after researchers accounted for factors like age, relationship length, and use of hormonal contraceptives, suggesting that something specific to PCOS is at work rather than just demographic overlap.4Human Reproduction. Sexual dysfunction in women with PCOS: a case control study
Why Higher Androgens Don’t Mean Higher Desire
This is the part that surprises most people. Testosterone is often treated as a simple dial for sex drive, so you might assume that a condition defined partly by excess androgens would come with heightened desire. The research says otherwise. A 2025 case-control study in Fertility and Sterility looked specifically at the relationship between androgen levels and sexual responses in women with PCOS and found only weak associations. Androgen levels explained a maximum of about 6% of the variation in any sexual response measure, and the few associations that did emerge involved specific androgens and very specific contexts, like fantasy-based arousal, not desire in a broader sense.5PubMed. Sexual response in women with polycystic ovary syndrome: a case-control study
One reason for this disconnect is that PCOS tends to come packaged with elevated insulin levels, which in turn can lower sex hormone-binding globulin (SHBG). Lower SHBG means more free testosterone circulating in the bloodstream, but this doesn’t appear to boost desire the way a straightforward “more testosterone equals more libido” model would predict. The hormonal environment in PCOS is not like taking supplemental testosterone in a healthy body. It’s a metabolically disrupted state where insulin resistance, inflammation, and irregular ovulation all interact. In a study of young women with PCOS, the differences in sexual function between PCOS women and controls persisted even after statistically adjusting for testosterone levels, suggesting that testosterone itself isn’t the main culprit.6The Journal of Sexual Medicine. Impaired Sexual Function in Young Women with PCOS: The Detrimental Effect of Anovulation
Anovulation Appears to Be a Bigger Driver Than Androgen Excess
If androgens aren’t doing the damage, what is? One of the more striking findings in recent research is that anovulation, the failure to regularly release an egg during a menstrual cycle, seems to matter much more for sexual function than hormone levels alone. A study comparing PCOS women who still ovulated regularly to those who didn’t found that the ovulatory PCOS group had sexual function scores essentially indistinguishable from healthy controls. It was the anovulatory group that showed significantly worse scores across desire, arousal, lubrication, orgasm, and satisfaction.7The Journal of Sexual Medicine. Impaired Sexual Function in Young Women with PCOS: The Detrimental Effect of Anovulation
In that same study, the odds of sexual dysfunction remained three to four times higher in the PCOS group even after adjusting for both BMI and hormone levels. The researchers concluded that anovulation itself, not androgen excess, was the primary mechanism impairing sexual response. This makes biological sense: ovulation involves a coordinated surge of hormones, including estrogen and progesterone, that affects mood, energy, and pelvic blood flow. Women who chronically don’t ovulate miss those cyclical peaks, which appear to play a role in maintaining baseline desire and arousal over time.
Body Image, Hirsutism, and the Psychological Toll
PCOS produces a cluster of visible symptoms that can erode how a person feels about their body, and body image has a well-documented relationship with sexual desire. Excess hair growth on the face and body, acne that persists well past adolescence, thinning scalp hair, and weight gain concentrated around the abdomen can all make a person feel less attractive or less comfortable being physically intimate. Meta-analyses on the topic have found that body image frequently has a negative impact on sexual thoughts and fantasies in women with PCOS.8Journal of Psychosexual Health. Polycystic Ovary Syndrome (PCOS) and Sexual Dysfunctions
Hirsutism in particular seems to carry an outsized effect. In one study, hirsutism severity significantly affected every domain of sexual function except pain during intercourse.9PubMed Central. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains This was true independent of BMI and hormone levels. It’s not hard to see why: unwanted facial or body hair can make a woman feel self-conscious during intimacy in ways that directly suppress desire and arousal. The effect operates through psychology, not physiology, but the impact on libido is just as real.
Depression and anxiety are also considerably more common in PCOS, and both are well-established suppressors of sexual desire on their own. Research has found a clear relationship between depressive and anxiety symptoms and reduced sexual functioning in women with the condition.10PubMed Central. Psychological Issues and Sexual Function in Women with Different Infertility Causes: Focus on Polycystic Ovary Syndrome A cluster analysis examining sexual function profiles in PCOS found that clinical and psychosocial characteristics, particularly BMI, abdominal fat distribution, and body image, exerted an equally important or even greater influence on sexual dysfunction than the PCOS diagnosis itself.11PubMed Central. Multivariate Profiles of Female Sexual Function: A Cluster Analysis of FSFI Domains in Women with and Without PCOS In other words, two women with PCOS can have very different sexual experiences depending on how the condition manifests for each of them psychologically.
Weight and Metabolic Factors
Excess weight, particularly central obesity, appears to be an independent risk factor for sexual dysfunction in PCOS. One study found that having a waist-to-hip ratio above 0.80 roughly doubled the odds of sexual dysfunction in the PCOS group, and higher BMI carried similarly elevated risk.12PubMed. Sexual function and depression in polycystic ovary syndrome: Is it associated with inflammation and neuromodulators? Women with a normal BMI in the PCOS group had significantly better desire and satisfaction scores than those who were overweight or obese.13PubMed Central. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains
This does not mean that weight loss is a simple fix, but it does mean that the metabolic features of PCOS, like insulin resistance and chronic low-grade inflammation, likely contribute to sexual difficulties through pathways that go beyond self-image. Insulin resistance affects blood flow, energy levels, and neurotransmitter balance, all of which feed into sexual responsiveness. The entanglement of metabolic and psychological factors is one reason PCOS-related libido issues don’t usually respond to a single intervention.
Not All PCOS Looks the Same
PCOS is diagnosed across four recognized phenotypes based on different combinations of androgen excess, ovulatory dysfunction, and polycystic ovarian morphology on ultrasound. These phenotypes don’t all carry the same risk for sexual difficulties. A cross-sectional study comparing sexual function across all four phenotypes found significant differences, with phenotype B, characterized by androgen excess combined with anovulation but without the classic polycystic ovarian appearance, showing the lowest overall sexual function scores.14PubMed Central. Female sexual function in different phenotypes of polycystic ovarian syndrome: a comparative cross-sectional study
A separate study of Chinese women with PCOS confirmed this pattern, finding that phenotypes A and B, which both feature anovulation and androgen excess, had the highest rates of sexual dysfunction risk, at roughly 88% and 82% respectively, compared to around 71% for phenotype D, the mildest form. Even the control group had a 61% rate of being at risk, illustrating that sexual difficulties are common in general, but the more metabolically severe forms of PCOS clearly pile on additional risk.15PubMed. Sexual function in Chinese women with different clinical phenotypes of polycystic ovary syndrome It’s worth noting, though, that at least one study found no significant difference between PCOS phenotypes and healthy controls on sexual function scores, so the picture is not perfectly settled.16PubMed. Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes
The practical takeaway here is that if you have a milder PCOS phenotype, especially one without chronic anovulation, your risk of libido problems is lower. If your phenotype involves persistent anovulation and significant androgen excess, the risk climbs meaningfully.
How Common PCOS Medications Affect Libido
Many women with PCOS are prescribed medications that can independently affect sexual function, sometimes in unwanted directions. Understanding these effects is important because a drop in libido that seems like “PCOS getting worse” might actually be a side effect of treatment.
Oral contraceptive pills are among the most commonly prescribed treatments for managing androgen-related symptoms. They lower free testosterone by boosting SHBG, which can help with acne and unwanted hair. However, a trial that tracked women with PCOS on oral contraceptives over a follow-up period found no change in any sexual function domain, suggesting the pills neither helped nor hurt libido on their own.17PubMed Central. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome That’s a neutral finding in the trial’s context, but in the broader population some women do report reduced desire on combined oral contraceptives, so individual responses vary.
Spironolactone, an anti-androgen frequently prescribed for hirsutism and acne in PCOS, carries its own risks. Clinical observations have found that women taking spironolactone can develop vestibular atrophy and tenderness, leading to painful intercourse and impaired arousal. In documented cases, stopping the drug and applying a topical hormone gel resolved both the tissue changes and the sexual complaints.18PubMed. Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder If you’re on spironolactone and noticing new pain during sex or declining arousal, that connection is worth raising with your doctor.
Metformin, on the other hand, appears to have a positive effect on sexual function. One early study found that women with PCOS reported higher satisfaction with their sex life and more frequent intercourse after metformin treatment.19PubMed. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality A more recent study tracking women over six months of metformin use found significant improvements across nearly every sexual function domain, including desire, arousal, lubrication, orgasm, and satisfaction, alongside improvements in body image and mental health scores.20The Journal of Sexual Medicine. METABOLIC, HORMONAL AND SEXUAL PROFILE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME BEFORE AND AFTER A SIX-MONTH TREATMENT WITH METFORMIN Another study specifically examining metformin in PCOS found increases across all sexual function domain scores, with statistically significant improvements in overall sexual function, lubrication, and pain.21Advances in Sexual Medicine. Sexual Function in Patients with PCOS and/or Obesity before and after Metformin Treatment The benefit likely comes through improved insulin sensitivity, weight management, and restored ovulatory cycles rather than any direct effect on sex drive.
Exercise and Therapy as Non-Drug Approaches
For women who want to address PCOS-related libido changes without adding medication, physical activity has genuine evidence behind it. A study examining physical resistance training in women with PCOS found significant improvements in overall sexual function scores, with the desire, arousal, and lubrication domains all showing meaningful gains after the training program.22The Journal of Sexual Medicine. Impact of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary Syndrome A separate trial found that lifestyle modifications, including exercise and dietary changes, improved sexual function when used alongside hormonal contraceptives, even though the contraceptives alone did not produce change.23PubMed Central. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome Strength training in particular may help through multiple channels at once: reducing insulin resistance, improving body composition, boosting mood, and enhancing body image.
Psychological therapy also shows promise. A trial comparing cognitive-behavioral therapy (CBT) to emotionally focused therapy in women with PCOS found that both approaches produced lasting improvements in sexual function, with CBT showing a somewhat stronger effect. The gains persisted at follow-up, meaning they weren’t just temporary boosts from the novelty of treatment.24International Journal of Behavioral Sciences. Comparing the Effectiveness of Emotionally Focused Therapy and Cognitive-Behavioral Therapy on Sexual Function and Health-Promoting Behaviors in Women with PCOS Given how heavily body image, depression, and anxiety contribute to sexual difficulties in PCOS, therapy that targets those pathways makes intuitive sense. It’s not treating the hormones; it’s treating the experience of living with the hormones.
When to Bring It Up With Your Doctor
Sexual function is notoriously under-discussed in PCOS management. Most clinical visits focus on metabolic markers, fertility planning, and symptom management for acne or hirsutism. Libido and sexual satisfaction tend to fall off the conversation unless the patient raises them, and many women don’t, either because they assume it’s not related or because the topic feels awkward.
If your sexual desire has changed since your PCOS diagnosis, or since starting a new PCOS medication, that’s clinically relevant information. It’s especially worth mentioning if you’ve started spironolactone and are experiencing new pain during intercourse, if you’ve gained significant weight and noticed a simultaneous drop in desire, or if depression or anxiety has worsened alongside your sexual difficulties. These aren’t three separate problems; they’re interconnected features of the same condition, and treating one often helps the others. A doctor who is only managing your androgen levels or your menstrual regularity is seeing part of the picture. Libido is another part, and addressing it often means looking at the metabolic and psychological dimensions of PCOS that blood work alone doesn’t capture.